Abu Dhabi Investment Authority and GIC led a $300m funding round in Taibang Biologic.

Synopsis

Sovereign wealth funds Abu Dhabi Investment Authority and GIC led a $300m funding round in Taibang Biologic, a biopharmaceutical firm. The proceeds will be used to finance its expansion of plasma stations and its research and development of new products.

Principals

target

Taibang Biologic

bidder

Gic Private

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Dealmakers

Service Providers (2)

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.